NCT03640052View on ClinicalTrials.gov

Pharmacological Activation of HMN for OSA

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

October 30, 2018

Primary Completion Date

September 30, 2019

Study Completion Date

December 31, 2019

Conditions
Obstructive Sleep Apnea
Interventions
DRUG

Placebo oral capsule

Placebo capsule before sleep

DRUG

LTM1201L

LTM1201L capsule before sleep

DRUG

LTM1201LN

LTM1201LN capsule before sleep

DRUG

LTM1201LB

LTM1201LB capsule before sleep

DRUG

LTM1201LD

LTM1201LD capsule before sleep

Trial Locations (2)

02115

Brigham and Women's Hospital, Boston

Sleep Disorders Research Program Brigham and Women's Hospital, Boston

All Listed Sponsors
lead

Brigham and Women's Hospital

OTHER

NCT03640052 - Pharmacological Activation of HMN for OSA | Biotech Hunter | Biotech Hunter